Author:
Pramitha Esha Nirmala Dewi
Affiliation:
Universitas Muhammadiyah Yogyakarta, Indonesia
Keyword(s):
Percutaneous Coronary Intervention, Response Evaluation, Yogyakarta
Abstract:
Coronary Artery Disease (CAD) is the main cause of mortality in heart disease. Its treatment involves complex therapies, such as pharmacological Percutaneous Coronary Intervention (PCI) to widen the clogged artery and lifestyle intervention to decrease the severity of CAD and restenosis. The complexity of the pharmacological therapy received by CAD patients may cause Adverse Drug Reaction (ADR) events. Therefore, this study aimed to identify the response of CAD patients after receiving PCI therapy at the Regional Hospital in Bantul, Yogyakarta. This descriptive research used retrospective data and a total population sampling method. The samples were CAD outpatients who had received PCI at this hospital from January to September 2017 and met the inclusion criteria. The sample size was 65 patients. The results showed that the responses of the CAD patients to PCI therapy included restenosis symptoms (70.77%) (namely, one restenosis symptom (43.08%) and two restenosis symptoms (27.69%)),
uncontrolled lifestyle intervention (namely, abnormalities in total cholesterol (58.62%), LDL cholesterol (93.10%), HDL cholesterol (72.41%), triglyceride (70.69%), blood pressure (72.22%), and HbA1c (50%)), and adverse drug reaction (4.62%).
(More)